Siobhan Bacon1,2, Dylan Burger3, Mayur Tailor3, J Johanna Sanchez4, George Tomlinson2,5, Helen R Murphy6,7,8, Denice S Feig9,10,11. 1. Mount Sinai Hospital, Sinai Health System, Toronto, ON, Canada. 2. Department of Medicine, University of Toronto, Toronto, ON, Canada. 3. Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada. 4. Sunnybrook Research Institute, Toronto, ON, Canada. 5. University Health Network, Toronto, ON, Canada. 6. Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. 7. Norwich Medical School, University of East Anglia, Norwich, UK. 8. Women's Health Academic Centre, Division of Women and Children's Health, Kings College London, London, UK. 9. Mount Sinai Hospital, Sinai Health System, Toronto, ON, Canada. d.feig@utoronto.ca. 10. Department of Medicine, University of Toronto, Toronto, ON, Canada. d.feig@utoronto.ca. 11. Lunenfeld-Tanenbaum Research Institute, Toronto, ON, Canada. d.feig@utoronto.ca.
Abstract
AIMS/HYPOTHESIS: Maternal hyperglycaemia alone does not explain the incidence of large offspring amongst women with type 1 diabetes. The objective of the study was to determine if there is an association between placental function, as measured by angiogenic factors, and offspring birthweight z score in women with type 1 diabetes. METHODS: This cohort study included samples from 157 Continuous Glucose Monitoring in Pregnant Women with Type 1 Diabetes (CONCEPTT) trial participants. Correlations were estimated between birthweight z score and placental growth factor (PlGF) and soluble fms-like tyrosine kinase (sFlt-1) levels measured at baseline and at 24 and 34 weeks of gestation. Linear regression was used to assess the relationship between birthweight z score and placental health, as measured by PlGF and sFlt-1/PlGF ratio, stratified by glycaemic status (continuous glucose monitoring and HbA1c measures) and adjusted for potential confounders of maternal BMI, smoking and weight gain. Higher PlGF levels and lower sFlt-1/PlGF ratios represent healthy placentas, while lower PlGF levels and higher sFlt-1/PlGF ratios represent unhealthy placentas. RESULTS: Among CONCEPTT participants, the slopes relating PlGF levels to birthweight z scores differed according to maternal glycaemia at 34 weeks of gestation (p = 0.003). With optimal maternal glycaemia (HbA1c < 48 mmol/mol [6.5%]/ or continuous glucose monitoring time above range ≤ 30%), birthweight z scores were reduced towards zero (normal weight) with increasing PlGF values (representing a healthy placenta), and increased with decreasing PlGF values. With suboptimal glycaemic status (HbA1c ≥ 48 mmol/mol [6.5%] or time above range > 30%), increasing PlGF values were associated with heavier infants. Those with a healthy placenta (PlGF > 100) and suboptimal glycaemic control had a higher mean z score (2.45) than those with an unhealthy placenta (mean z score = 1.86). Similar relationships were seen when using sFlt-1/PlGF ratio as a marker for a healthy vs unhealthy placenta. CONCLUSIONS/ INTERPRETATION: In women with type 1 diabetes, infant birthweight is influenced by both glycaemic status and placental function. In women with suboptimal glycaemia, infant birthweight was heavier when placentas were healthy. Suboptimal placental function should be considered in the setting of suboptimal glycaemia and apparently 'normal' birthweight.
AIMS/HYPOTHESIS: Maternal hyperglycaemia alone does not explain the incidence of large offspring amongst women with type 1 diabetes. The objective of the study was to determine if there is an association between placental function, as measured by angiogenic factors, and offspring birthweight z score in women with type 1 diabetes. METHODS: This cohort study included samples from 157 Continuous Glucose Monitoring in Pregnant Women with Type 1 Diabetes (CONCEPTT) trial participants. Correlations were estimated between birthweight z score and placental growth factor (PlGF) and soluble fms-like tyrosine kinase (sFlt-1) levels measured at baseline and at 24 and 34 weeks of gestation. Linear regression was used to assess the relationship between birthweight z score and placental health, as measured by PlGF and sFlt-1/PlGF ratio, stratified by glycaemic status (continuous glucose monitoring and HbA1c measures) and adjusted for potential confounders of maternal BMI, smoking and weight gain. Higher PlGF levels and lower sFlt-1/PlGF ratios represent healthy placentas, while lower PlGF levels and higher sFlt-1/PlGF ratios represent unhealthy placentas. RESULTS: Among CONCEPTT participants, the slopes relating PlGF levels to birthweight z scores differed according to maternal glycaemia at 34 weeks of gestation (p = 0.003). With optimal maternal glycaemia (HbA1c < 48 mmol/mol [6.5%]/ or continuous glucose monitoring time above range ≤ 30%), birthweight z scores were reduced towards zero (normal weight) with increasing PlGF values (representing a healthy placenta), and increased with decreasing PlGF values. With suboptimal glycaemic status (HbA1c ≥ 48 mmol/mol [6.5%] or time above range > 30%), increasing PlGF values were associated with heavier infants. Those with a healthy placenta (PlGF > 100) and suboptimal glycaemic control had a higher mean z score (2.45) than those with an unhealthy placenta (mean z score = 1.86). Similar relationships were seen when using sFlt-1/PlGF ratio as a marker for a healthy vs unhealthy placenta. CONCLUSIONS/ INTERPRETATION: In women with type 1 diabetes, infant birthweight is influenced by both glycaemic status and placental function. In women with suboptimal glycaemia, infant birthweight was heavier when placentas were healthy. Suboptimal placental function should be considered in the setting of suboptimal glycaemia and apparently 'normal' birthweight.
Authors: Monica Autiero; Johannes Waltenberger; Didier Communi; Andrea Kranz; Lieve Moons; Diether Lambrechts; Jens Kroll; Stephane Plaisance; Maria De Mol; Françoise Bono; Stefanie Kliche; Guido Fellbrich; Kurt Ballmer-Hofer; Domenico Maglione; Ulrike Mayr-Beyrle; Mieke Dewerchin; Saskia Dombrowski; Danica Stanimirovic; Paul Van Hummelen; Christoph Dehio; Daniel J Hicklin; Graziella Persico; Jean-Marc Herbert; David Communi; Masabumi Shibuya; Désiré Collen; Edward M Conway; Peter Carmeliet Journal: Nat Med Date: 2003-07 Impact factor: 53.440
Authors: Kate E Duhig; Jenny Myers; Paul T Seed; Jenie Sparkes; Jessica Lowe; Rachael M Hunter; Andrew H Shennan; Lucy C Chappell Journal: Lancet Date: 2019-04-01 Impact factor: 79.321
Authors: Sharon T Mackin; Scott M Nelson; Joannes J Kerssens; Rachael Wood; Sarah Wild; Helen M Colhoun; Graham P Leese; Sam Philip; Robert S Lindsay Journal: Diabetologia Date: 2018-01-11 Impact factor: 10.122
Authors: Denice S Feig; Lois E Donovan; Rosa Corcoy; Kellie E Murphy; Stephanie A Amiel; Katharine F Hunt; Elizabeth Asztalos; Jon F R Barrett; J Johanna Sanchez; Alberto de Leiva; Moshe Hod; Lois Jovanovic; Erin Keely; Ruth McManus; Eileen K Hutton; Claire L Meek; Zoe A Stewart; Tim Wysocki; Robert O'Brien; Katrina Ruedy; Craig Kollman; George Tomlinson; Helen R Murphy Journal: Lancet Date: 2017-09-15 Impact factor: 79.321